Dr. Hamara Altaf, Dr Abdul Qadeer Khan, Dr. Ramsha Saleem
Objective: The objective of the study is to assess the outcomes of ESWL for urinary stones using the Sonolith R vision lithotripter. Place and Duration: In the Urology Unit II of Mayo Hospital Lahore for one year duration from March 2019 to February 2020. Patients and methods: 463 patients were analyzed retrospectively, including 451 patients aged 18 to 93 (mean 56.32 years) of which 62% of men and 38% of women experienced ESWL for solitary urinary stones at the lithotripsy unit. The most common ureter locations were 98 distal (lower) ureter patients (52%), and the most common kidney locations were 126 renal pelvis (46.49%). The mean diameter of the stone was 1.41 cm (1.02 ureteral and 1.8 cm kidney). 56% of patients received ESWL under cover of pethidine IV diluted 50 mg as sedation. Results: Our 463 patients required a whole of 672 meetings of ESWL. The average number of meetings per calculation was 1.425 (range 1-6). The % of patients requiring a sole session was 72.3%. The re-treatment rate was 25% for ureteral stones and 32% for kidney stones. Treatment was more operative on ureteral stones. Other supportive procedures such as DJ stent placement and ureteroscopy were needed in 56 (12%) patients. Conclusion: As a result, we originate that Sonolith R's vision is a safe and operative device for treating urinary stones in selected patients. Keywords: Extracorporeal Shock Wave Lithotripsy, Sessions, Indicator Without Stones.